About Onconaut Therapeutics
Onconaut Therapeutics is a private company based in Aurora, Colorado, incorporated in 2022 in Delaware. It has reported $125,000 raised in one offering on Form D since November 2024. Its chief executive is Daniel LaBarbera.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Oct 21, 2024 | Nov 4, 2024 | $125,000fully sold | 1 | $125K | Debt, Promissory note convertible into equity securities of the Issuer and the equity securities to be issued upon such conversionRule 506(b) | Form D ↗ |
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Onconaut Therapeutics's Form D filed Nov 4, 2024.
DL
Daniel LaBarbera
Chief Executive Officer and director